Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000460536 | SCV000555828 | likely benign | Bloom syndrome | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256283 | SCV002529459 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-26 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002256283 | SCV002562883 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-11-12 | criteria provided, single submitter | clinical testing | The c.2691C>T variant (also known as p.S897S), located in coding exon 13 of the BLM gene, results from a C to T substitution at nucleotide position 2691. This nucleotide substitution does not change the amino acid at codon 897. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice acceptor site. Based on the available evidence, the clinical significance of this variant remains unclear. |
Natera, |
RCV000460536 | SCV002088104 | likely benign | Bloom syndrome | 2018-11-15 | no assertion criteria provided | clinical testing |